Ann Hollenbeck

Ann Hollenbeck advises clients in the health care and life sciences industry on digital health, artificial intelligence, human subjects research, organ transplant, pharmacy/340B, and fraud and abuse matters. Ann also represents hospitals, academic medical centers, and technology companies, as well as ambulatory surgery centers and telemedicine providers, in such transactional matters as mergers and acquisitions, joint ventures, and physician-hospital co-ownership and co-management arrangements. She regularly advises these entities on the negotiation of clinical trial-related agreements, including virtual clinical trials, in addition to related regulatory matters, such as Medicare reimbursement and institutional review board responsibilities.